Molecular genetics of autosomal-dominant axonal charcot-marie-tooth disease

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

The autosomal-dominant axonal peripheral neuropathies comprise a genetically heterogeneous group of disorders that are clinically subsumed under Charcot-Marie-Tooth disease type 2 (CMT2). A significant increase in the number of genes underlying major forms of CMT2 has improved the classification of specific CMT phenotypes. The molecular dissection of cellular functions of the related gene products has only begun and detailed pathophysiological models are still missing, but already the biological scope of genes linked to CMT2 is more diversified than CMT1. The known CMT2 genes present key players in these pathways and will likely prove as powerful tools in identifying eventual future targets for therapeutic intervention.

Original languageEnglish
Pages (from-to)63-74
Number of pages12
JournalNeuroMolecular Medicine
Volume8
Issue number1-2
DOIs
StatePublished - Mar 1 2006
Externally publishedYes

Fingerprint

Charcot-Marie-Tooth Disease
Molecular Biology
Genes
Peripheral Nervous System Diseases
Dissection
Phenotype

Keywords

  • Axonal neuropathy
  • Charcot-Marie-Tooth disease
  • HMSN II
  • Motor neuropathy, CMT2

ASJC Scopus subject areas

  • Neuroscience(all)
  • Genetics
  • Cell Biology

Cite this

Molecular genetics of autosomal-dominant axonal charcot-marie-tooth disease. / Zuchner, Stephan L; Vance, Jeffery M.

In: NeuroMolecular Medicine, Vol. 8, No. 1-2, 01.03.2006, p. 63-74.

Research output: Contribution to journalArticle

@article{2c19fee1c753427b9197fcf2b5368266,
title = "Molecular genetics of autosomal-dominant axonal charcot-marie-tooth disease",
abstract = "The autosomal-dominant axonal peripheral neuropathies comprise a genetically heterogeneous group of disorders that are clinically subsumed under Charcot-Marie-Tooth disease type 2 (CMT2). A significant increase in the number of genes underlying major forms of CMT2 has improved the classification of specific CMT phenotypes. The molecular dissection of cellular functions of the related gene products has only begun and detailed pathophysiological models are still missing, but already the biological scope of genes linked to CMT2 is more diversified than CMT1. The known CMT2 genes present key players in these pathways and will likely prove as powerful tools in identifying eventual future targets for therapeutic intervention.",
keywords = "Axonal neuropathy, Charcot-Marie-Tooth disease, HMSN II, Motor neuropathy, CMT2",
author = "Zuchner, {Stephan L} and Vance, {Jeffery M}",
year = "2006",
month = "3",
day = "1",
doi = "10.1385/NMM:8:1:63",
language = "English",
volume = "8",
pages = "63--74",
journal = "NeuroMolecular Medicine",
issn = "1535-1084",
publisher = "Humana Press",
number = "1-2",

}

TY - JOUR

T1 - Molecular genetics of autosomal-dominant axonal charcot-marie-tooth disease

AU - Zuchner, Stephan L

AU - Vance, Jeffery M

PY - 2006/3/1

Y1 - 2006/3/1

N2 - The autosomal-dominant axonal peripheral neuropathies comprise a genetically heterogeneous group of disorders that are clinically subsumed under Charcot-Marie-Tooth disease type 2 (CMT2). A significant increase in the number of genes underlying major forms of CMT2 has improved the classification of specific CMT phenotypes. The molecular dissection of cellular functions of the related gene products has only begun and detailed pathophysiological models are still missing, but already the biological scope of genes linked to CMT2 is more diversified than CMT1. The known CMT2 genes present key players in these pathways and will likely prove as powerful tools in identifying eventual future targets for therapeutic intervention.

AB - The autosomal-dominant axonal peripheral neuropathies comprise a genetically heterogeneous group of disorders that are clinically subsumed under Charcot-Marie-Tooth disease type 2 (CMT2). A significant increase in the number of genes underlying major forms of CMT2 has improved the classification of specific CMT phenotypes. The molecular dissection of cellular functions of the related gene products has only begun and detailed pathophysiological models are still missing, but already the biological scope of genes linked to CMT2 is more diversified than CMT1. The known CMT2 genes present key players in these pathways and will likely prove as powerful tools in identifying eventual future targets for therapeutic intervention.

KW - Axonal neuropathy

KW - Charcot-Marie-Tooth disease

KW - HMSN II

KW - Motor neuropathy, CMT2

UR - http://www.scopus.com/inward/record.url?scp=33745261763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745261763&partnerID=8YFLogxK

U2 - 10.1385/NMM:8:1:63

DO - 10.1385/NMM:8:1:63

M3 - Article

C2 - 16775367

AN - SCOPUS:33745261763

VL - 8

SP - 63

EP - 74

JO - NeuroMolecular Medicine

JF - NeuroMolecular Medicine

SN - 1535-1084

IS - 1-2

ER -